Infigratinib

INN name:	Infigratinib
Lab codes:	BGJ-398; NVP-BGJ398
Chemical name:	N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-{6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl}-N-methylurea
Molecular formula:	C26H31Cl2N7O3
Chemical Structure:	Add caption
CAS Registry Number:	872511-34-7
Originator:	Novartis
Class:	Antineoplastics
Mechanism of Action:	Tyrosine kinase inhibitor
WHO ATC code:	L01X-E
EPhMRA code:	L1H
Clinical Trials:
Conditions Phases Interventions Status Advanced Cholangiocarcinoma Phase 2 Alone Recruiting Melanoma Phase 2 Combination Active, not recruiting Melanoma Phase 2 Combination Recruiting Recurrent Glioblastoma or Other Glioma Subtypes Phase 2 Alone Recruiting Solid Tumor|Hematologic Malignancies Phase 2 Alone Recruiting Advanced Gastrointestinal Stromal Tumor (GIST) Phase 1|Phase 2 Combination Recruiting Advanced Solid Malignancies Phase 1 Alone Recruiting Advanced Solid Tumors,|Metastatic Solid Tumors Phase 1 Combination Recruiting Cancer of Cervix|Tumors Phase 1 Combination Withdrawn Tumor With Alterations of the FGF-R Phase 1 Alone Recruiting